News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh
Photo collage of Laura Bukavina and Phillip Abbosh
Jul 4, 2024, 13:06

Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh

Laura Bukavina, Urologic Oncologist at Cleveland Clinic, shared on X:

“The NTACT residual disease test, eloquently presented by Phillip Abbosh published in JCO Precision Oncology. Remarkably, over 50% of patients without visible residual disease had positive mutations, indicative of field cancerization—mutations present in adjacent normal tissue WITHOUT cancer. NTACT demonstrated 91% sensitivity and 82% accuracy.”

Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh

Read further.
Source: Laura Bukavina/X

cancer cancer mutations Cleveland Clinic field cancerization JCO Precision Oncology Laura Bukavina NTACT OncoDaily Oncology oncology research Phillip Abbosh Precision Medicine residual disease test Urologic Oncologist
Special Coverage
Blog
Aug 3, 2025, 18:06
Norah Shire: Societal Aspect of Lung Cancer Needs to Be Addressed
Insight
Aug 3, 2025, 17:55
Jia Liu: DEP SN38 Early Phase Clinical Trial Results Published in JCO
Blog
Aug 3, 2025, 17:38
Pat Soon-Shiong: Trying Hard for the Cancer Community
Blog
Aug 3, 2025, 17:15
Support from Three Young Bakers - World Child Cancer
Science
Aug 3, 2025, 17:14
Jordan Gauthier: B-Cell Maturation Antigen CAR T-Cell Therapy for RRMM
Insight
Aug 3, 2025, 17:02
Dr. Bishal Gyawali – Challenging the Status Quo Award: Yvonne Awards 2025
Insight
Aug 3, 2025, 17:01
Hafsa Elmarrachi: Strategic Synthesis of Breakthrough Clinical Advances in Lung and GI Cancers Presented at ASCO 2022 and 2023
Science
Aug 3, 2025, 16:42
Myeloma Paper of the Day, August 3rd, Suggested by Robert Orlowski
Blog
Aug 3, 2025, 16:34
Nina Niu Sanford: Excited to See Harvey Mamon as Co-Chair of the NCI GI Steering Committee
Blog
Aug 3, 2025, 16:24
William Aird: What Determines the ESR?
Blog
Aug 3, 2025, 16:12
Angela Morabito's Talk at MGH for the American Lung Cancer Screening Initiative - Florez Lab
Blog
Aug 3, 2025, 16:06
Bridging the Gap in the Diagnosis and Management of Lung Cancer - The Institute of Cancer and Crisis